US$ 28.21
black box warning glp 1 Before you panic about the “black warning,” read this. As an endocrinologist, I see too many thyroid patients scared away from GLP-1 medications because of misinformation. Let's simplify it: • Hashimoto's? Swissmedic issues warning against falsified
Description
Nat Commun 10(1):139

Liou JH, Liu YM, Chen CH

SAVINGS UPDATE For the lowest cash price

These drugs are highly effective but terribly expensive, generally costing $8,000-$10,000 per patient annually, even after rebates and discounts

As a result, patients with largely postprandial hyperglycaemia are more likely to benefit from treatment with short-acting GLP1-RAs as opposed to individuals with predominantly fasting hyperglycaemia, who would derive greater benefit from long-acting agents [52]

This improvement in outcomes is larger than the improvement expected from other interventions, including expensive drugs used in heart failure